Le Lézard
Classified in: Health, Science and technology
Subjects: TDS, FVT

Aspen Spotlight Health 360° VIDEO PREMIERE: New Virtual Reality Video Takes You Inside The Lab with Researchers to Showcase Amazing Advancements in Medicine


ASPEN, Colo., June 22, 2017 /PRNewswire-USNewswire/ -- America's biopharmaceutical companies released a new virtual reality video highlighting innovation and a new era of groundbreaking advancements today to kick off Spotlight Health, the opening segment of the annual 2017 Aspen Ideas Festival.

Pharmaceutical Research and Manufacturers of America.(PRNewsFoto/PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA)

The 360° immersive video experience takes viewers inside a biopharmaceutical lab, where amazing discoveries are being made in science through the use of genomics-based research. The video provides valuable insights into the real-life laboratory experience happening every day, and how the new era of medicine is helping power scientific advancements that improve patient lives.

The video is part of GOBOLDLY, a multi-year national campaign showcasing the work of industry researchers who are driving cutting-edge advances in science.

Representatives from Pharmaceutical Research and Manufacturers of America (PhRMA) will be available to speak to the industry's efforts in pioneering new treatments and the future of medicine, along with other health policy issues. Members of the media are welcome to visit the exhibit and check out the 360° video during the Spotlight Health conference.

WHAT: America's Biopharmaceutical Companies' GoBoldly Exhibit & 360° Video Experience

WHEN: Thursday June 22 from 8:30 am ? 5:00 pm  
Friday June 23 from 8:30 am ? 5:00 pm  
Saturday June 24 from 8:30 am ? 5:00 pm

WHERE: The East Lawn (across the street from the Paepcke Memorial Building)

WHO: Representatives from PhRMA will be available for interviews while onsite. Please direct all interview requests to [email protected].

FOR YOUR RADAR: In addition to the exhibit for America's biopharmaceutical companies, Stephen J. Ubl, President & CEO of PhRMA, will participate in a panel discussion Friday morning June 23rd examining the value medicines bring patients and how payment and delivery systems can meet 21st century demands. 

Learn more about the campaign at GoBoldly.com and Innovation.org.

About PhRMA
The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country's leading innovative biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier and more productive lives. Since 2000, PhRMA member companies have invested more than half a trillion dollars in the search for new treatments and cures, including an estimated $58.8 billion in 2015 alone.

 

SOURCE Pharmaceutical Research and Manufacturers of America (PhRMA)


These press releases may also interest you

at 08:38
Empower Community Care, a leading global behavioral health and education organization, is thrilled to announce that it has been honored with the prestigious Pacesetter Award for 2024. Presented annually by the Atlanta Business Chronicle, the...

at 08:35
Takeda (TSE:4502/NYSE:TAK) today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of fruquintinib, a selective inhibitor of vascular endothelial growth factor...

at 08:35
Bio-Rad Laboratories, Inc. , a global leader in life science research and clinical diagnostics products, today announced the promotion of James J. Barry, currently Senior Vice President of Global Manufacturing, to the position of Executive Vice...

at 08:33
1MD Nutrition, a leading developer of physician-formulated, condition-specific nutritional supplements with key ingredients in therapeutically significant dosages from substantiated, human clinical trials, is now a "Proud Partner" of the...

at 08:25
NOVA LEAP HEALTH CORP. ("Nova Leap" or "the Company"), a growing home health care organization, is pleased to announce that it has executed a definitive agreement (the "Agreement"), dated April 25, 2024, to acquire a home care services company ("the...

at 08:20
Coya Therapeutics, Inc. ("Coya" or the "Company"), a clinical-stage biotechnology company developing biologics intended to enhance regulatory T cell (Treg) function, announces that Dr. Stanley Appel, M.D., Chairman of Coya's Scientific Advisory...



News published on and distributed by: